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CharacterizationAbstract The aim of this study was to investigate pharmaceutical potentialities of a polymeric
microparticulate drug delivery system for modulating the drug proﬁle of poorly water-soluble quer-
cetin. In this research work two cost effective polymers sodium alginate and chitosan were used for
entrapping the model drug quercetin through ionic cross linking method. In vitro drug release,
swelling index, drug entrapment efﬁciency, Fourier Transforms Infrared Spectroscopy (FTIR),
Scanning Electron Microscopy (SEM), X-ray Diffraction (XRD) and Differential Scanning Calo-
rimetric (DSC) studies were also done for physicochemical characterization of the formulations.
Swelling index and drug release study were done at a pH of 1.2, 6.8 and 7.4 to evaluate the GI
mimetic action which entails that the swelling and release of the all the Formulation1 (F1), Formu-
lation2 (F2) and Formulation3 (F3) at pH 1.2 were minimal conﬁrming the prevention of drug
release in the acidic environment of stomach. Comparatively more sustained release was seen from
the formulations F2 & F3 at pH 6.8 and pH 7.4 after 7 h of drug release proﬁling. Drug entrapment
efﬁciency of the formulations shows in F1 (D:C:A = 2:5:30) was approximately 70% whereas the
increase in chitosan concentration in F2 (D:C:A = 2:10:30) has shown an entrapment efﬁciency of
81%. But the comparative further increase of chitosan concentration in F3 (D:C:A = 2:15:30) has
shown a entrapment of 80% which is not having any remarkable difference from F2. The FTIR
analysis of drug, polymers and the formulations indicated the compatibility of the drug with the
polymers. The smoothness of microspheres in F2 & F3 was conﬁrmed by Scanning Electron
Microscopy (SEM). However F1 microsphere has shown more irregular shape comparatively.
The DSC studies indicated the absence of drug-polymer interaction in the microspheres. Our
430 M. Hazra et al.XRD studies have revealed that when pure drug exhibits crystalline structure with less dissolution
proﬁle, formulated microparticles can help us to obtain amorphous form of the same drug that is
likely to have more dissolution property. The ﬁndings of the study suggest that the microsphere
formulations were a promising carrier for quercetin delivery and can be considered as a favorable
oral controlled release dosage form for hydrophobic drug quercetin.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Researchers have treasured the potential beneﬁts of micro
technology in providing vast improvements in drug delivery.
The method by which a drug is delivered can have a notewor-
thy effect on its efﬁcacy. One of the most attractive areas of
research in drug delivery today is the design of micro-particu-
late systems that are able to deliver drugs to the right place, at
appropriate times and at the right dosage. Recently, the idea of
using microparticles made from natural biodegradable poly-
mers to deliver drugs has provoked great interests. Among
them, keeping the cost effectiveness in mind two polymers have
been used alginate and chitosan which are very promising and
have been widely subjugated in pharmaceutical industry for
controlling drug release as revealed from the previous article
of Hamidi et al., 2008.
Gombotz and Wee (1998), Smidsrod and Skjakbraek (1990)
and Murata et al. (2007) have reported that alginate can be
used as mucoadhesive, biodegradable and has prospective for
numerous pharmaceutical and biomedical applications such
as drug delivery system and cell encapsulation. Chitosan, a lin-
ear polysaccharide consisting of glucosamine and N-acetyl glu-
cosamine units, is biocompatible, biodegradable, and nontoxic
in the application of peroral delivery of drugs as reported by
Kotze et al. (1999) and Shi et al. (2008).
The drug Quercetin has been extensively investigated for its
antioxidant, antitumor, hepatoprotective activity by the previ-
ous researchers like Inal and Kahraman (2000), Hertog et al.
(1992), Kanadaswami et al. (2005). But at the same time it
has been noticed in spite of having so many therapeutic effect
oral administration of quercetin has been limited by its poor
bioavailability which can be evidenced from the work of
Davis et al., 2000. Several attempts were made for increasing
the bioavailability of the quercetin by different researchers
including the complexation with cyclodextrin and liposome
as seen in the work of Jessy and Sneha (2012). Nevertheless,
the use of cyclodextrin is associated with a risk of nephrotox-
icity and employing liposome might incur stability problems
during storage as supported by the work of Frijlink et al.
(1990). However no attempts have been made for increasing
the oral bioavailability of quercetin by incorporating the drug
in the matrix of biopolymers like chitosan and sodium alginate
which on the other hand promises the drug delivery to a higher
intestinal pH in which the drug is soluble enough.
It is therefore clear that a safe, stable, and efﬁcient delivery
method in increasing the solubility of quercetin is warranted.
In the present research work quercetin microparticulate system
has been prepared by a simple ionic cross linking technology
with sodium alginate and chitosan as carriers and also the
effect of the chitosan concentration on drug release proﬁle
has been evaluated. Physicochemical characterization of theformulations has been done by in vitro drug swelling index
study, Scanning Electron Microscopy (SEM), differential scan-
ning calorimetry (DSC), powder X-ray Diffraction (XRD),
Fourier transform infrared spectroscopy (FT-IR).
2. Experimental
2.1. Materials
Chitosan, 75–85% deacetylated, intermediate viscosity
(Brookﬁeld, 1% solution in acetic acid) 20–300 cP, sodium
alginate and quercetin were purchased from Sigma Aldrich,
India. The other entire reagent used was of analytical grade.
2.2. Preparation of quercetin microparticles
The formulations were made according to the described
method of the previous researcher Wittaya-areekul et al.
(2006). Brieﬂy all the chitosan solutions (0.5%, 1% and
1.5%w/v) were prepared by dissolving chitosan in a solution
of 1% acetic acid followed by the addition of 4% calcium chlo-
ride. The whole solution was homogenized at 500 r.p.m for
1 h. The sodium alginate solution at a concentration of 3%
(w/v) was prepared. After complete mixing of sodium alginate
quercetin was added in the concentration of 0.2% (w/v). The
sodium alginate-drug solution was then dropped to the chito-
san–calcium chloride solution through a 0.45 mm syringe nee-
dle at a dropping rate of 1.0 ml/min. The microparticles were
allowed to harden for 2 h before washing them and were then
dried at room temperature.
2.3. Microparticles characterization
2.3.1. Determination of Drug Entrapment Efﬁciency (DEE)
The quercetin content was determined by dissolving 100 mg of
microparticles in phosphate buffer of pH 7.4 under sonication
(Front line sonicator FS600) for 30 min until the microparti-
cles were completely dissolved. After that the samples
were ﬁltered and analyzed spectrophotometrically (Thermo
Spectronic, UK) at 370 nm.
The encapsulation efﬁciency was calculated using the
following formula.
Drug entrapment efficiency ð%Þ
¼ ðcalculated drug concentration=
theoretical drug concentrationÞ  100
2.3.2. In vitro release studies
Drug release proﬁles from alginate/chitosan microparticles
containing quercetin with an accurately weighed amount of
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II (Erweka, Germany). The study conditions were set at a stir-
ring speed of 75 r.p.m, dissolution medium volume of 500 ml
at 37 C. The dissolution mediums were simultaneously
0.1 N HCl buffer pH 1.2, phosphate buffer pH 6.8 and pH
7.4 as a representative of the gastric and intestinal ﬂuids
respectively. The samples were ﬁltered and analyzed spectro-
photometrically at 370 nm. The results measured in triplicate
are expressed as a percentage of the drug released.
2.3.3. Swelling index study
Swelling study for microsphere was conducted by immersing
the microsphere in 50 ml of three respective medias namely,
simulated gastric ﬂuid pH 1.2 and simulated intestinal ﬂuid
phosphate buffer pH 6.8 and pH 7.4. Increase in weight of
the microsphere was determined at preset time interval until
a constant weight was observed by using Mettler Toledo single
pan electronic balance.
Swelling index was then calculated as:
Swelling index ¼ ðmass of swollen microspheres
mass of dry microspheres=
mass of dried microspheresÞ  100:
2.3.4. Imaging through high resolution digital scanning
microscope
The images of the microspheres were taken using high resolu-
tion scanning microscope (RMM SCOPE, India). Randomly
chosen microparticles were taken to measure their individual
shape and morphology. Microparticles were visualized under
30· magniﬁcation.
2.3.5. Scanning electron microscopy
The surface morphology of the microparticles was examined
using scanning electron microscopy (Jeol Datum Ltd.,
G5/IL/42/08. Tokyo, Japan). Samples were deposited on
stub using one side of a double-sided adhesive dried carbon
tape (NEM Tape, Nisshin Em. Co. Ltd., Tokyo, Japan). The
working distance 25 mm was maintained and acceleration
voltage used was 17 kV with secondary electro image (SEI)
as a detector.
2.3.6. Drug excipients interaction study by Fourier Transforms
Infrared Spectroscopy
Fourier Transform Infrared Spectrum of pure quercetin,
chitosan, sodium alginate, alginate–chitosan physical mixture
and drug loaded microsphere were recorded in range ofTable 1 Drug entrapment efﬁciency (DEE), release proﬁle after 7 h
FMSb Ratio of D:C:Ac DEE% % Drug release proﬁle aft
1.2 6.8
F1 2:5:30 70 ± 3.4 25.79 ± 2.8 79.45 ± 2
F2 2:10:30 81.59 ± 4.8 20.78 ± 2.5 65.29 ± 2
F3 2:15:30 80.33 ± 2.9 18.57 ± 1.8 63.45 ± 3
a Each observation is the mean ± S.D (n= 3).
b FMS – Formulation code.
c D:C:A – Drug:Chitosan:Na-alginate.4000–400 cm1 using FT-IR (Perkin Elmer) from KBr pellet
to ﬁnd out the drug excipient compatibility study.
2.3.7. Differential scanning calorimetry
A DSC thermogram of pure drug and drug loaded formulated
microparticle was performed to determine the thermal proper-
ties of the drug and that of formulations. The thermogram was
covered by heating from 32.00 C to 400.00 C at 12 C/min.
The vessel is constantly purged with nitrogen at a rate of
20.0 mL/min by using PerkinElmer (SINGAPORE)
instruments, (DTA, Osaka, Japan).
2.3.8. X-ray diffraction Analysis
This study is useful to investigate crystallinity of the drug in
cross-linked microspheres. It was performed with X-ray
diffractometer (ULTIMA-III, Rigaku, Japan), using nickel-
ﬁltered Cu Ka radiation (a voltage of 40 kV and a current of
30 mA) for pure drug and formulated microparticles.
3. Results & discussion
3.1. Drug entrapment efﬁciency study results
All the three microparticulate formulations were evaluated for
drug entrapment efﬁciency and the results were illustrated in
Table 1 which shows that the entrapment efﬁciency was
affected by the chitosan concentration which reﬂects that with
the increase in polymer ratio the drug entrapment in the poly-
mer matrix get increased. F1 is having the minimum drug
entrapment efﬁciency of approximately 70% whereas the
entrapment efﬁciency of F2 with Drug:Chitosan:Alginate ratio
of 2:10:30 shows an approximate entrapment of 80%. How-
ever, no signiﬁcant differences were found in the quercetin
entrapment efﬁciency between the microparticles of F2 and
F3 prepared with varied chitosan to sodium alginate concen-
tration. This could be revealed as the increase in polymer con-
centration has signiﬁcant effect on the drug entrapment
efﬁciency.
3.2. In vitro drug release study results
Figs. 1–3 are showing the in vitro drug release from F1, F2 and
F3 respectively which was carried out for 7 h in 500 mL of
three different physiological pH buffer solution (namely pH
7.4, pH 6.8 and pH 1.2). Formulation F1 has shown minimum
amount of drug release at pH 1.2 which is 25%. But a sudden
release rate was observed at pH 6.8 and pH 7.4 which wereand swelling index of all the 3 formulationsa.
er 7 h at pH Swelling index
7.4 1.2 6.8 7.4
.0 87.2 ± 1.9 195.6 ± 4.5 715.2 ± 4.1 850.5 ± 5.1
.9 78.45 ± 2.0 170.5 ± 4.7 653.9 ± 4.5 756.2 ± 5.0
.5 72.15 ± 2.7 150.5 ± 4.6 620.1 ± 4.6 715.4 ± 4.85
Figure 2 Drug release study from F2 at different physiological
pH. Each observation is the mean ± SD (n= 3).
Figure 3 Drug release study from F3 at different physiological
pH. Each observation is the mean ± SD (n= 3).
Figure 4 Swelling index study of F1 at different physiological
pH. Each observation is the mean ± SD (n= 3).
Figure 5 Swelling index study of F2 at different physiological
pH. Each observation is the mean ± SD (n= 3).
Figure 6 Swelling index study of F3 at different physiological
pH. Each observation is the mean ± SD (n= 3).
Figure 1 Drug release study from F1 at different physiological
pH. Each observation is the mean ± SD (n= 3).
432 M. Hazra et al.respectively 79% and 87%. The sudden release could be due to
less polymer concentration of F1. On the other hand F2 and
F3 have a minimum release of 20% and 18% respectively at
stomach pH environment of pH 1.2. A steady drug release
of 65% & 78% from F2 and 63% & 72% from F3 has been
noted at pH 6.8 and pH 7.4. The results of the dissolution
study indicated that the amount of drug release appreciably
decreased and became steady with an increase in the concen-
tration of chitosan in the matrix. It can be ascribed to increase
in the densities of the polymer matrix ensuing in larger micro-
spheres and this in turn increases the diffusional path length,
which the drug molecules have to traverse as supported bythe preceding work of Sultana et al., 2009 in preparation of dil-
tiazem microspheres. Drug release study also entails that the
release from all the Formulation1 (F1), Formulation2 (F2)
and Formulation3 (F3) at pH 1.2 was minimal conﬁrming
the prevention of drug release in the acidic environment of
stomach.
3.2.1. Swelling index study results
The swelling behavior of the microspheres shown in Figs. 4–6
was studied by measuring the water uptake at deﬁnite time
intervals in pH 1.2, pH 6.8 and pH 7.4. In pH 1.2, the ratio
of water uptake by the microspheres of all three formulations
was low and independent of time. However gradual increase in
chitosan concentration in F1, F2 and F3 controlled the
Figure 7 High resolution digital imaging of F1 microparticle at
30· magniﬁcation.
Figure 8 High resolution digital imaging of F2 microparticle at
30· magniﬁcation.
Figure 9 High resolution digital imaging of F3 microparticle at
30· magniﬁcation.
Figure 10 SEM photomicrograph of drug-loaded microparticle
of F1.
Figure 11 SEM photomicrograph of drug-loaded microparticle
of F2.
Designing polymeric microparticulate drug delivery system 433swelling of microsphere at all the three buffers. The maximum
water uptake for all three formulations was seen for 7 h. More
or less up to this stage microspheres behave as matrix for con-
trolled release of incorporated drug, after which erosion and
break down of microspheres occurred.
3.2.2. Analysis reports of imaging through high resolution digital
scanning microscope
This imaging technology provided us a rough thought on the
shape and surface morphology of the microspheres without
scaling of the particles in a magniﬁcation of 30·. Figs. 7–9
show the images of F1, F2 and F3 microparticles enlightening
that the particles of F2 and F3 were having a superior shape
and surface morphology whereas the microparticles of F1 hav-
ing a lesser chitosan concentration could not be competentenough to create an even polymer matrix reasoning the lower
drug entrapment efﬁciency of F1 than other two formulations.
3.2.3. Results of scanning electron microscopy
The SEM photomicrograph shown in Figs. 10 and 11 was the
images of drug loaded microspheres of F1 and F2 respectively.
F2 microspheres were almost spherical in shape with rough
and nonporous surface. The micrographs of F1 were not good
enough than that of the other two formulations showing
almost ﬂat beads instead of a spherical one. The result shows
that the polymer concentration in the formulations actually
affects the surface morphology of the microspheres reasoning
for the uneven pellet type of shape for the Formualtion1 where
the polymer concentration was less. Formulation2 having a
polymer to drug ratio as (D:C:A = 2:10:30) has shown a more
spherical shape and smooth surface morphology with opti-
mum results in drug release and swelling index proﬁling which
is supported by the work of Motlekar and Youan (2008).
However formulation3 with a polymer to drug ratio as
Table 2 Details about the spectral lines which have been found in the FTIR graph.
Functional groups Wave number
for chitosan
(cm1)
Wave number
for Na-alginate
(cm1)
Wave number
for quercetin
(cm1)
Wave number for
chitosan Na-Alg
physical mixture
(cm1)
Wave number
for F1 (cm1)
Wave number
for F2 (cm1)
Wave number
for F3 (cm1)
AOH stretching 3407 3408 3415 3407 3419 3428 3428
AOH bending 1467 1466 1467 1467 1465 1467 1467
CH stretching 2973 2973 2973 2973 2973 (sharp peak) 2973 2973
CO stretching – 1642 – – – – –
Aromatic rings 1564 1564 1563 1564 1559 1563 1562
AC‚CA 2360 2360 2360 2360 – 2359 2359
Figure 12 DSC curves of formulation (in blue) and pure drug (in red).
434 M. Hazra et al.(D:C:A = 2:15:30) has shown a more rigid structure for which
the drug release proﬁle results were not reasonable.
3.2.4. Drug excipients interaction study results by Fourier
Transforms Infrared Spectroscopy
Chitosan ﬂakes, Na-alginate and their physical mixture along
with the formulations have shown characteristic peaks around
3400 cm1 for –OH and –NH2 stretching. CH stretching at
2973 cm1 has been seen very signiﬁcantly in formulation1
but is not signiﬁcant in other formulations. In sodium alginate
some distinct peaks such as carboxyl group showed strong
absorption bands at 1642 cm1 due to carboxyl anions asym-
metric and symmetric stretching vibrations disappearing orbecoming weak in the microparticle formulations which have
shown the evidence of multi-interactions (hydrogen binding
and electrostatic interaction) among chitosan and alginate
molecules supporting the previous work of Zhang et al.,
2008. However all of the FTIR reports have shown –OH
stretching at 3420 cm1 and –OH bending at around
1467 cm1. Also there were signiﬁcant peaks from 1600 to
1500 cm1 due to the presence of amine group present in chito-
san. This observation indicated that there was no signiﬁcant
intermolecular interaction occurred in the physical mixtures
and also in the formulations. The details about the spectral
lines which have been found in the FTIR graph have been tab-
ulated in Table 2.
Figure 13 X-ray diffraction patterns of pure quercetin.
Figure 14 X-ray diffraction patterns of formulations.
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DSC report in Fig. 12 shows the quercetin powder used in this
study had a sharp melting endothermic peak (marked by the
red line) at 316 C followed by degradation supporting the
melting point of quercetin. However, no melting point peak
was exhibited in the curve of formulation (marked in blue line).
A similar observation has been reported by Jung et al., 1999.
These results suggested that the drug was dispersed throughout
the polymers forming a high-energy amorphous state.
3.2.6. X-ray diffraction analysis
The characteristic peaks of quercetin exhibited at a diffraction
angle of 2h, 10.73, 12.33, 15.87, 24.41, 26.50, and 27.40
Fig. 13, can be inferred to traits of a high crystalline structure.
However, there were no characteristic peaks appearing on the
patterns of the formulation Fig. 14. One explanation for this is
that the molecule of quercetin has been encapsulated or dis-
persed into chitosan–alginate polymers when undergoing theionic cross linking technique, thus forming an amorphous
complex with intermolecular interaction occurring within the
matrix. A similar phenomenon has been observed for oridonin
dispersed in poly(D,L-lactic acid) (PLA) in which the XRD pat-
tern of oridonin-loaded PLA nanoparticles showed that the
drug was in its amorphous state by Xing et al. (2007). Findings
of the present study were also in accordance with the above
results and also from the DSC analysis providing evidence
has been found that the crystal structure of quercetin was
indeed converted to an amorphous state.
4. Conclusion
Quercetin appears to have limited therapeutic window through
oral route, which is demanding to produce an ideal delivery
technique to increase the therapeutic concentration in vivo.
The present study has shown that chitosan-coated alginate
microspheres could be a challenging controlled drug delivery
436 M. Hazra et al.system for quercetin with more therapeutic bioavailability.
Similar result has been observed by Sarmento et al. (2007)
for the oral delivery of insulin through alginate/chitosan nano-
particles. Hence, it can be concluded that using these cost
effective polymers can develop a novel drug delivery system
of herbal drug quercetin which can increase the bioavailability
of the compound for several degenerative diseases.
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